Guardion Health Science (GHSI) Short-Term Debt to Capital

Guardion Health Science (GHSI) specializes in the development of ophthalmological nutraceuticals, maintaining a reputation as an expert in the prevention of ocular aging. Current price action on GURU.Markets, where the indicator stands at 0.00, is coupled with risks stemming from expensive advertising campaigns and dependence on raw material suppliers. Meanwhile, the business has effectively ceased development and is liquidating its structure following the sale of its primary medical nutrition assets.

The commercialization of Lumega-Z nutraceuticals and specialized nutrition for patients with macular degeneration requires precise liquidity management, which is reflected in the ratio of current liabilities to equity for Guardion Health Science (GHSI). This metric assesses the dependence of operational activities on short-term borrowing, allowing the balance between the risk of a cash gap and the efficiency of financial leverage to be determined through the dynamics of short-term loans relative to equity.